國家醫保局:引導口腔種植醫療服務合理價格並組建採購聯盟
國家醫保局就《關於開展口腔種植醫療服務收費和耗材價格專項治理的通知(徵求意見稿)》公開徵求意見提出,種植牙牙冠實行掛網採購,公立醫療機構根據臨床需求自主選擇,並按實際採購價格「零差率」銷售。
具體採購方案由四川省醫療保障局會同各聯盟省份醫療保障部門制定並組織實施,牽頭組建種植牙耗材省際採購聯盟,並在省內對臨床主流的全瓷牙冠組織競價掛網,通過競爭形成合理市場價格,其他材質參照全瓷冠的價格掛網。
徵求意見稿提出,種植牙耗材集中帶量採購堅持招採合一、量價掛鉤的基本原則,按照政府組織、聯盟採購、平台操作的總體思路,充分考慮種植牙耗材生產、供應和臨床使用等方面的特點,引導企業公平競爭。(ta/s) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.